(Q37350974)

19 August 2017

A cross-national study of the persistence of antihypertensive medication use in the elderly (English)

1 reference

19 August 2017

Sebastian Schneeweiss

series ordinal

4

object named as

Sebastian Schneeweiss

1 reference

19 August 2017

2

William H Shrank

1 reference

19 August 2017

6

Jerry Avorn

1 reference

19 August 2017

5

M Alan Brookhart

1 reference

19 August 2017

Boris L G van Wijk

1

1 reference

PMC publication ID

2745820

19 August 2017

Olaf H Klungel

series ordinal

3

1 reference

19 August 2017

1 January 2008

1 reference

19 August 2017

Journal of Hypertension

1 reference

19 August 2017

26

1 reference

19 August 2017

1

1 reference

19 August 2017

145-153

1 reference

Interventions used to improve control of blood pressure in patients with hypertension

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Feasibility of treating prehypertension with an angiotensin-receptor blocker

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

6 September 2017

Adherence to Medication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Global burden of hypertension: analysis of worldwide data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Hypertension treatment and control in five European countries, Canada, and the United States

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Compliance and persistence with newer antihypertensive agents

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

A survey of population-based drug databases in Canada.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Medicaid data as a resource for epidemiologic studies: strengths and limitations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

14 September 2017

Reference-based pricing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing".

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Rate and determinants of 10-year persistence with antihypertensive drugs.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Policy implications of the gradient of health and wealth

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745820

The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimen

2 September 2018

1 reference

12 December 2020

Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy

1 reference

12 December 2020

Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study

1 reference

12 December 2020

Health care for older persons, a country profile: The Netherlands

1 reference

12 December 2020

Noncompliance may cause half of antihypertensive drug "failures"

1 reference

12 December 2020

Persistence of use of lipid-lowering medications: a cross-national study

1 reference

12 December 2020

The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers

1 reference

12 December 2020

Antihypertensive drug therapy in Saskatchewan: patterns of use and determinants in hypertension

1 reference

12 December 2020

Long-term persistence in use of statin therapy in elderly patients

1 reference

12 December 2020

Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation

1 reference

12 December 2020

The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions

1 reference

12 December 2020

Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice

1 reference

12 December 2020

10.1097/HJH.0B013E32826308B4

Identifiers

DOI

1 reference

19 August 2017

1 reference

PMC publication ID

2745820

19 August 2017

PubMed publication ID

18090552

1 reference

PMC publication ID

2745820